HomeAI · summaries
Storia in 3 fonti
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
Following in the footsteps of Gilead Sciences, Merck & Co. | Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory submissions.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.
- ·
endpoints.news
Novo asks court to block Lilly ads; Merck strikes HIV PrEP deal
Novo Nordisk sues Eli Lilly over misleading ads; Merck licenses alimatravir; AbbVie/Genmab clarify Epkinly trial; J&J touts Talvey/Tecvayli data; MannKind gets FDA nod.
